A 56-year-old with NSTEMI is being discharged. Which dual antiplatelet therapy is recommended in most patients (no high bleeding risk) post-PCI?...

Question

A 56-year-old with NSTEMI is being discharged. Which dual antiplatelet therapy is recommended in most patients (no high bleeding risk) post-PCI?

Accepted Answer

Aspirin plus ticagrelor (with loading then maintenance)

Answer

Aspirin plus clopidogrel 75 mg long-term without loading

Answer

Aspirin alone

Answer

Clopidogrel alone

Answer

Aspirin plus warfarin

ukmla MCQ (SBA): ACS secondary prevention